Mirasol Pathogen Reduction Technology(®) treatment does not affect acute lung injury in a two-event in vivo model caused by stored blood components

INTRODUCTION: Mirasol Pathogen Reduction Technology(®) (PRT) treatment uses riboflavin and UV light to inactivate pathogens in blood components. Neutrophil [polymorphonuclear cells (PMN)] priming activity accumulates during routine storage of cellular blood components, and this activity has been imp...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Silliman, C. C., Khan, S. Y., Ball, J. Bradley, Kelher, M. R., Marschner, S.
Médium: Artigo
Jazyk:Inglês
Vydáno: 2009
Témata:
Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC3132808/
https://ncbi.nlm.nih.gov/pubmed/19951305
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/j.1423-0410.2009.01289.x
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky